RESUMEN
Despite the eradication of smallpox, orthopoxviruses (OPV) remain public health concerns. Efforts to develop new therapeutics and vaccines for smallpox continue through their evaluation in animal models despite limited understanding of the specific correlates of protective immunity. Recent monkeypox virus challenge studies have established the black-tailed prairie dog (Cynomys ludovicianus) as a model of human systemic OPV infections. In this study, we assess the induction of humoral immunity in humans and prairie dogs receiving Dryvax, Acam2000, or Imvamune vaccine and characterize the proteomic profile of immune recognition using enzyme-linked immunosorbent assays (ELISA), neutralization assays, and protein microarrays. We confirm anticipated similarities of antigenic protein targets of smallpox vaccine-induced responses in humans and prairie dogs and identify several differences. Subsequent monkeypox virus intranasal infection of vaccinated prairie dogs resulted in a significant boost in humoral immunity characterized by a shift in reactivity of increased intensity to a broader range of OPV proteins. This work provides evidence of similarities between the vaccine responses in prairie dogs and humans that enhance the value of the prairie dog model system as an OPV vaccination model and offers novel findings that form a framework for examining the humoral immune response induced by systemic orthopoxvirus infection.
Asunto(s)
Anticuerpos Antivirales/sangre , Interacciones Huésped-Patógeno , Monkeypox virus/inmunología , Monkeypox virus/patogenicidad , Infecciones por Poxviridae/inmunología , Proteoma/análisis , Vacuna contra Viruela/inmunología , Animales , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Humanos , Pruebas de Neutralización , Infecciones por Poxviridae/patología , Análisis por Matrices de Proteínas , Sciuridae , Vacuna contra Viruela/administración & dosificaciónRESUMEN
OBJECTIVE: To determine the influence of the dose of collagen given nasally on the induction of specific mucosal tolerance in collagen-induced arthritis. METHODS: The severity of clinical arthritis induced in DBA/1 mice was studied after the nasal administration (before disease induction) of 1 of 4 doses (across a 2-log range) of bovine type II collagen (CII). Parameters of immunity included lymphocyte proliferation and cytokine production in vitro in response to antigen stimulation, and the production of anticollagen IgG antibody subclasses. RESULTS: The 3 highest doses (20, 80, and 320 microg) ameliorated disease severity, whereas the lowest dose (5 microg) aggravated disease. These findings correlated well with antigen-specific T cell proliferation and cytokine and antibody production. T cell proliferation was suppressed by the higher doses of CII, whereas the low dose enhanced T cell proliferation, indicating it primed the T cells. Suppression of T cell proliferation could be overcome by the addition of exogenous interleukin-2 (IL-2) to these cultures. Decreased T cell proliferation was associated with suppression of both Th1 (interferon-gamma [IFNgamma]) and Th2 (IL-4) cytokines and all the subclasses of anticollagen IgG in mice receiving 20, 80, or 320 microg of collagen. Overall, the highest dose of collagen (320 microg) was less effective at suppressing the immune response and disease than the 20-microg or 80-microg doses. There was an increased production of antibodies of all IgG isotypes, and of the Th1-associated cytokines IFNgamma and IL-2, in animals that had received the lowest dose of 5 microg collagen nasally. CONCLUSION: Nasal administration of antigens is effective in inducing tolerance and reducing disease severity, but the effects are dose dependent. Low doses can prime the immune system and aggravate disease; high doses may not suppress disease. Suppression of the immune response, which correlates with suppression of disease, is not obviously associated with a type I to type II T cell switch, but rather with an overall suppression of both forms of T cell response, with a potential role for anergy of T cells in this process.
Asunto(s)
Artritis/inmunología , Colágeno/administración & dosificación , Terapia de Inmunosupresión , Administración Intranasal , Animales , Artritis/patología , Artritis/terapia , Linfocitos B/efectos de los fármacos , Linfocitos B/inmunología , Células Cultivadas , Colágeno/inmunología , Colágeno/farmacología , Citocinas/inmunología , Relación Dosis-Respuesta a Droga , Inmunidad Mucosa , Inmunoglobulina G/sangre , Interleucina-2/farmacología , Activación de Linfocitos/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos DBA , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunologíaRESUMEN
BACKGROUND: Symptoms of disease reported by patients reflect the effects of the disease process within the individual and the person's physical and mental ability to tolerate or otherwise cope with the limitations on their functioning. This study examines the relationship between asthma symptoms, disease severity, and psychological status in patients being managed in routine primary healthcare settings. METHODS: One hundred and fourteen subjects from four GP practices, two inner city and two suburban, were studied. Symptoms were assessed by means of the Asthma Quality of Life questionnaire (AQLQ) and a locally devised Q score, and psychological status with the Hospital Anxiety and Depression (HAD) scale. Spirometric values and details of current asthma treatment (BTS asthma guidelines treatment step) were recorded as markers of asthma severity. RESULTS: Symptoms as measured by AQLQ correlated with peak expiratory flow (r(S) = 0.40) and with BTS guidelines treatment step (r(S) = 0.25). Similarly, the Q score correlated with peak expiratory flow (r(S) = 0.44) and with BTS guidelines treatment step (r(S) = 0.42). Similar levels of correlation of forced expiratory volume in one second (FEV(1)) with symptoms were reported. HAD anxiety and depression scores also correlated to a similar extent with these two symptom scores, but there was hardly any correlation with lung function. Logistic regression analysis showed that HAD scores help to explain symptom scores over and above the effects of lung function and BTS guidelines treatment step. Symptoms, depression, and anxiety were higher for inner city patients while little difference was observed in objective measures of asthma. CONCLUSIONS: Asthma guidelines suggest that changing levels of symptoms should be used to monitor the effectiveness of treatment. These data suggest that reported symptoms may be misleading and unreliable because they may reflect non-asthma factors that cannot be expected to respond to changes in asthma treatment.
Asunto(s)
Trastornos de Ansiedad/etiología , Asma/psicología , Trastorno Depresivo/etiología , Administración por Inhalación , Adolescente , Corticoesteroides/administración & dosificación , Adulto , Asma/fisiopatología , Broncodilatadores/administración & dosificación , Estudios de Cohortes , Femenino , Volumen Espiratorio Forzado/fisiología , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Ápice del Flujo Espiratorio/fisiología , Calidad de Vida , Características de la Residencia , Salud Suburbana , Encuestas y Cuestionarios , Salud Urbana , Capacidad Vital/fisiologíaRESUMEN
Examination of chromatograms of karyotyped larvae of Anopheles gambiae s.s. and Anopheles arabiensis has revealed that there are differences in the profile of their epicuticular hydrocarbons. A discriminant analysis of the quantitative hydrocarbon data has shown that the An. gambiae Mopti 2Rbc/bc karyotype from Mali could be separated from the Forest 2La/a karyotype from Liberia in > 80% of cases. Similar analysis permitted > 80% separation of individuals of two karyotypes of Anopheles arabiensis: 2Rab/ + from Burkina Faso, and 2Rb/b from Madagascar.
Asunto(s)
Anopheles/clasificación , Hidrocarburos/análisis , Insectos Vectores/clasificación , Animales , Anopheles/química , Anopheles/genética , Cromatografía de Gases/métodos , Análisis Discriminante , Insectos Vectores/química , Insectos Vectores/genética , Cariotipificación , Larva/química , Larva/clasificación , Larva/genética , Parasitología/métodos , Especificidad de la EspecieRESUMEN
Cytokine induced levels of ICAM-1 expressed by rat brain-endothelial cells were quantitated by enzyme immunoassay in response to stimulation by TNF-alpha in the presence or absence of IFN-gamma. The rat strains investigated differ in their susceptibility to experimental allergic encephalomyelitis; significantly less ICAM-1 was induced by BEC derived from the resistant PVG strain as compared to the susceptible LEW strain with both cytokine combinations. In contrast, despite the difference in disease susceptibility, equivalent levels of ICAM-1 were induced between the LEW and BN strain. Furthermore, evidence for a synergistic interaction of both TNF-alpha and IFN-gamma was observed in the BN strain. The results are discussed with relevance to the disease profile of each strain.
Asunto(s)
Circulación Cerebrovascular , Citocinas/fisiología , Endotelio Vascular/metabolismo , Molécula 1 de Adhesión Intercelular/metabolismo , Animales , Barrera Hematoencefálica , Células Cultivadas , Sinergismo Farmacológico , Endotelio Vascular/citología , Femenino , Interferón gamma/farmacología , Ratas , Ratas Endogámicas BN , Ratas Endogámicas Lew , Ratas Endogámicas , Proteínas Recombinantes/farmacología , Especificidad de la Especie , Factor de Necrosis Tumoral alfa/farmacologíaRESUMEN
Advances in understanding the role of dendritic cells (DCs) as the major antigen (Ag)-presenting cell type of the immune system combined with the recent development of methods for the ex vivo expansion of human DCs have opened the possibility for the transfer of tumor Ags to DCs with a view toward tumor immunotherapy. In this study, we examined the feasibility of Ag transfer to cultured human DCs using the host range-restricted avipoxvirus, fowlpoxvirus (FWPV). FWPV was found to infect and express a lacZ marker gene in a number of mammalian cell lines of fibroblastic, epithelial, and hemopoietic lineage origins. LacZ recombinant FWPV (rFWPV) was found subsequently to infect human DCs that had been cultured ex vivo from peripheral blood monocytes. Using rFWPV containing lacZ under the control of a vaccinia virus (VV) early/late promoter (p7.5K) and a 10 plaque-forming units per cell multiplicity of infection, >80% of cells expressed the lacZ marker gene. Quantitative analysis showed that the level of expression continued to rise for 5 days postinfection, at which point the experiments were terminated. Replication-competent recombinant VV (rVV) was also shown to be capable of transferring the marker gene to primary DC cultures. However, neither rFWPV nor rVV were able to express transgenes under the control of late viral promoters, indicating that both rFWPV and rVV infections are arrested at an early stage in human DCs. Infection of CD83 + DCs by rFWPV was confirmed by double-staining cytochemistry. We conclude that host range-restricted FWPV can be used efficiently to transfer Ag genes to human DCs ex vivo and may have a role in the development of tumor immunotherapy protocols.
Asunto(s)
Antígenos/genética , Avipoxvirus/genética , Células Dendríticas/metabolismo , Técnicas de Transferencia de Gen , Vectores Genéticos , Inmunoterapia/métodos , Animales , Línea Celular , Embrión de Pollo , Células Dendríticas/citología , Fibroblastos , Humanos , Factores de TiempoRESUMEN
Human papillomavirus type 6 (HPV-6) is the causative agent of condyloma acuminata, a common sexually transmitted disease. Virus-like particles (VLPs) assembled from the L1 major capsid protein represent promising candidates for prophylactic vaccines. However, any intratype sequence variation among HPV-6 L1 ORFs will influence which sequence is used for a vaccine according to its prevalence in the population and its propensity for VLP production. Therefore, we have analysed the entire L1 nucleotide sequence of 17 clinical isolates of HPV-6 from the London area. We found 28 positions where changes from the prototype HPV-6b L1 occurred, showing that HPV-6 L1 intratype variation is greater than previously reported. The most frequently observed substitutions are clustered into three discrete regions: R1 (nt 5920-6075), R2 (nt 6590-6670) and R3 (nt 7070-7230). Indeed, most of the nucleotide substitutions within the HPV-6 L1 reported worldwide also map to these regions. The R3 region contains predominantly non-silent substitutions, the most common of which is a G-to-C substitution at position 7079. This results in a Glu-to-Gln change at aa 431, although this change had no effect on VLP yield or stability. This substitution defines a new HPV-6 L1 amino acid sequence that is more abundant in the isolates examined than any other reported sequence.
Asunto(s)
Cápside/genética , Mutación , Sistemas de Lectura Abierta , Papillomaviridae/genética , Secuencia de Aminoácidos , Secuencia de Bases , Clonación Molecular , Humanos , Datos de Secuencia Molecular , Virión/fisiologíaRESUMEN
Cuticular lipids were extracted in hexane from the females of four strains of Anopheles stephensi and separated by capillary gas chromatography. When the chromatograms produced were quantified and compared by discriminant analysis, compositional variations in the hydrocarbons indicated that two of the strains, 'Russ' (originally isolated in the former (U.S.S.R.) and 'Iraq' (from Iraq), both of which were susceptible to DDT and malathion, could be confidently separated from 'Beech' from India and 'St Mal' from Pakistan, both of which were resistant to DDT and malathion. A high degree of hydrocarbon segregation between each of the four strains might be associated with geographical variation. It appears that there are significant and real differences in the hydrocarbons of these strains and these may be at least partially related to genetic alterations resulting from prior insecticide exposure. However, far more analysis is required if any relationship with prior exposure is to be confirmed.
Asunto(s)
Anopheles/química , Hidrocarburos/química , Animales , Anopheles/clasificación , Anopheles/efectos de los fármacos , Cromatografía de Gases , DDT , Femenino , Resistencia a los Insecticidas , Malatión , Especificidad de la EspecieRESUMEN
Monoclonal murine anti-pesticide antibodies were produced by in vitro immunisation (IVI) of cultured splenocytes with the pesticides sulcofuron and flucofuron. The majority of both anti-flucofuron and anti-sulcofuron antibodies obtained were of the IgM isotype, rather than IgG. When used in an indirect enzyme-linked immunosorbent assay (ELISA), the antibodies bound to plate coating antigens which incorporated haptens that mimicked moieties present within the immunising pesticide. The antibodies exhibited a high degree of specificity, with the degree of cross-reactivity related to the structural similarity between the hapten present in the plate coating antigen and the moieties present within the immunising pesticide. These results indicated that antibodies specific to both sulcofuron and flucofuron had been produced by IVI. Synthesis of both hapten analogues and immunogens as required for methods based on in vivo immunisation was avoided, whilst antibody production was also comparatively more rapid than traditional methods and minimised animal discomfort.
Asunto(s)
Anticuerpos Monoclonales/biosíntesis , Bencenosulfonatos/inmunología , Insecticidas/inmunología , Compuestos de Fenilurea/inmunología , Animales , Anticuerpos Monoclonales/análisis , Anticuerpos Monoclonales/química , Sitios de Unión de Anticuerpos , Unión Competitiva/inmunología , Ensayo de Inmunoadsorción Enzimática , Hibridomas , Ratones , Ratones Endogámicos BALB C , Mariposas NocturnasRESUMEN
ZD2767 represents an improved version of antibody-directed enzyme prodrug therapy. It consists of a conjugate of the F(ab')2 A5B7 antibody fragment and carboxypeptidase G2 (CPG2) and a prodrug, 4-[N,N-bis(2-iodoethyl)amino]phenoxycarbonyl L-glutamic acid. The IC50 of the prodrug against LoVo colorectal tumor cells was 47 microM, and cleavage by CPG2 released the potent bis-iodo phenol mustard drug (IC50 = 0.34 microM). The drug killed both proliferating and quiescent LoVo cells. Administration of the ZD2767 conjugate to nude mice bearing LoVo colorectal xenografts resulted in approximately 1% of injected ZD2767 conjugate localizing/g of tumor after 72 h, and blood and normal tissue levels of the conjugate were 10-50-fold lower. A single round of therapy involving the administration of the prodrug 72 h after the conjugate to athymic mice bearing established LoVo xenografts resulted in approximately 50% of the tumors undergoing complete regressions, tumor growth delays greater than 30 days, and little toxicity (as judged by body-weight loss). Similar studies using a control antibody-CPG2 conjugate that does not bind to LoVo tumor cells resulted in a growth delay of less than 5 days, confirming the tumor specificity of this approach. These studies demonstrate the potential of ZD2767 for the treatment of colorectal cancer.
Asunto(s)
Antineoplásicos Alquilantes/administración & dosificación , Neoplasias Colorrectales/tratamiento farmacológico , Compuestos de Mostaza Nitrogenada/administración & dosificación , Profármacos/administración & dosificación , Animales , Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Antineoplásicos/uso terapéutico , Femenino , Humanos , Inmunotoxinas/administración & dosificación , Ratones , Ratones Desnudos , Trasplante de Neoplasias , Trasplante Heterólogo , gamma-Glutamil Hidrolasa/metabolismoRESUMEN
Antibody-directed enzyme prodrug therapy (ADEPT) is a two-step approach for the treatment of cancer which seeks to generate a potent cytotoxic agent selectively at a tumor site. In this work described the cytotoxic agent is generated by the action of an enzyme CPG2 on a relatively nontoxic prodrug. The prodrug 1 currently on clinical trial is a benzamide and is cleaved by CPG2 to a benzoic acid mustard drug 1a. We have synthesized a series of new prodrugs 3-8 where the benzamide link has been replaced by, for example, carbamate or ureido. Some of these alternative links have been shown to be good substrates for CPG2 and therefore new candidates for ADEPT. The active drugs 3a and 4a derived from the best of these prodrugs are potent cytotoxic agents (1-2 microM) some 100 times more than 1a. The prodrugs 3 and 4 are some 100-200-fold less cytotoxic, in a proliferating cell assay, than their corresponding active drugs 3a and 4a.
Asunto(s)
Mostaza de Anilina/análogos & derivados , Antineoplásicos/síntesis química , Inmunotoxinas , Profármacos/síntesis química , gamma-Glutamil Hidrolasa/metabolismo , Mostaza de Anilina/síntesis química , Mostaza de Anilina/metabolismo , Mostaza de Anilina/farmacología , Muerte Celular , División Celular/efectos de los fármacos , Neoplasias Colorrectales/patología , Humanos , Estructura Molecular , Células Tumorales CultivadasRESUMEN
Immunostimulating complexes (ISCOMs) efficiently deliver soluble antigen into both the cytosolic (endogenous) and endosomal (exogenous) pathways of antigen processing. Cytosolic delivery to antigen-presenting cells (APCs) may therefore be useful for the stimulation and assay of class I major histocompatibility complex (MHC)-restricted cytotoxic T lymphocytes (CTL) in vitro. In this study, mice were immunized with ISCOMs containing fusion proteins of the E6 or E7 early proteins of human papilloma virus type 11 (HPV 11) to elicit CTL. These CTL were then restimulated in vitro using APCs pulsed with the same ISCOMs, prior to cytotoxicity assay using syngeneic target cells infected with recombinant vaccinia viruses. In this way, antigen-specific, MHC-restricted lysis by CD8+ cells was detected. However, this was dependent on the use of low density splenocytes as APCs for restimulation in vitro. Limiting dilution analyses showed a direct correlation between the CTL responder frequency and the number of times the animals were immunized in vivo. We conclude that in lieu of infectious virus, the use of ISCOMs to mediate antigen delivery to APCs in vitro can be used to quantitate CTL activity. This may have applications in monitoring vaccine efficacy, particularly to viruses such as HPV, which cannot be presently obtained as infectious virus in sufficient quantity for CTL propagation and assay.
Asunto(s)
ISCOMs/inmunología , Proteínas Oncogénicas Virales/inmunología , Papillomaviridae/inmunología , Linfocitos T Citotóxicos/inmunología , Vacunas Virales/inmunología , Animales , Antígenos H-2/análisis , ISCOMs/administración & dosificación , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Bazo/inmunología , Células Tumorales Cultivadas , Vacunas Sintéticas/inmunología , Vacunas Virales/administración & dosificaciónRESUMEN
Since the mitogenic action of EGF is mediated by ligand-induced autophosphorylation of the EGF receptor (EGFR), and EGFR is commonly overexpressed in solid human tumours, inhibitors of receptor tyrosine kinase activity (RTK) could prove to be effective antitumour agents. Screening of a compound library using an EGF-RTK enzyme prepared from human tumour derived A431 cells identified a series of potent (IC50 < 1 microM) enzyme inhibitors. These inhibitors are quinazolines bearing a variety of substituted anilines at the 4-position. The most potent 4-anilinoquinazolines (IC50 approximately equal to 20 nM) have small non-polar meta substituents on the aniline ring, and are competitive with ATP and non-competitive with substrate. The growth inhibitory activity of these agents was assessed in vitro using KB cells (human oral squamous tumour) grown in the absence or presence of EGF. A selected compound, 4-(3-chloroanilino)quinazoline (CAQ), inhibited EGF-stimulated growth in a concentration dependent manner and complete blockade was observed at concentrations (1-10 microM) which had no effect on basal growth. Selectivity of growth inhibition by CAQ was further exemplified in IGF1-stimulated KB cells where no effect was detected at concentrations which completely blocked EGF-stimulated growth. Similarly, CAQ blocked TGF alpha-stimulated growth in MCF-7 human breast cancer cells without affecting insulin-stimulated growth. These studies define a novel class of EGF-RTK inhibitors which are also potent and selective inhibitors of EGF-stimulated human tumour cell growth in vitro.
Asunto(s)
Antineoplásicos/farmacología , Inhibidores Enzimáticos/farmacología , Receptores ErbB/antagonistas & inhibidores , Quinazolinas/farmacología , Humanos , Células KB , Relación Estructura-Actividad , Células Tumorales CultivadasAsunto(s)
Terapia Enzimática , Inmunoconjugados/uso terapéutico , Neoplasias/terapia , Profármacos/uso terapéutico , Animales , Enzimas/administración & dosificación , Humanos , Inmunoconjugados/administración & dosificación , Compuestos de Mostaza/administración & dosificación , Compuestos de Mostaza/uso terapéutico , Trasplante de Neoplasias , Profármacos/administración & dosificación , Trasplante HeterólogoRESUMEN
ADEPT is an antibody-based targeting strategy for the treatment of cancer. We have developed two new prodrugs, 4-[N,N-bis(2-chloroethyl)amino]-phenoxycarbonyl-L- glutamic acid (PGP) and (S)-2-[N-[4-[N,N-bis(2-chloroethyl)amino]- phenoxycarbonyl]amino]-4-(5-tetrazoyl)butyric acid (PTP), which are cleaved by the bacterial enzyme CPG2 to release the 4-[N,N-bis(2-chloroethyl)amino] phenol drug. In vitro, both prodrugs are approximately 100- to 200-fold less potent than the parent drug (1 h IC50 = 1.4 microM) in LoVo colorectal tumour cells. These prodrugs have been evaluated for utility in ADEPT when used in combination with a conjugate of CPG2 and the F(ab')2 fragment of the anti-CEA monoclonal antibody, A5B7. The conjugate was shown to localise specifically to established LoVo tumour xenografts growing in nude mice and optimal tumour-normal tissue ratios were achieved after 72 h. Administration of either prodrug, at doses which cause 6-8% body weight loss, 72 h after administration of the A5B7-CPG2 conjugate to the LoVo tumour-bearing mice resulted in tumour regressions and growth delays of 14-28 days. The PTP prodrug in combination with a high dose of conjugate (10 mg kg-1) gave the best anti-tumour activity despite being a 10-fold worse substrate for CPG2 than PGP. Prodrug alone, active drug alone or prodrug in combination with a non-specific conjugate had minimal anti-tumour activity in this tumour model.
Asunto(s)
Mostaza de Anilina/análogos & derivados , Anticuerpos Monoclonales/administración & dosificación , Anticuerpos Antineoplásicos/administración & dosificación , Antineoplásicos Alquilantes/uso terapéutico , Proteínas Bacterianas/administración & dosificación , Antígeno Carcinoembrionario/inmunología , Neoplasias Colorrectales/tratamiento farmacológico , Inmunoconjugados/uso terapéutico , Profármacos/uso terapéutico , gamma-Glutamil Hidrolasa/administración & dosificación , Mostaza de Anilina/farmacocinética , Mostaza de Anilina/uso terapéutico , Animales , Anticuerpos Monoclonales/inmunología , Anticuerpos Antineoplásicos/inmunología , Antineoplásicos Alquilantes/farmacocinética , Proteínas Bacterianas/metabolismo , Biotransformación , Neoplasias Colorrectales/patología , Ensayos de Selección de Medicamentos Antitumorales , Femenino , Humanos , Fragmentos Fab de Inmunoglobulinas/administración & dosificación , Fragmentos Fab de Inmunoglobulinas/inmunología , Ratones , Ratones Desnudos , Trasplante de Neoplasias , Profármacos/farmacocinética , Pseudomonas/enzimología , Especificidad por Sustrato , Células Tumorales Cultivadas , gamma-Glutamil Hidrolasa/metabolismoRESUMEN
The resistance by T lymphocytes to activation by antigen (anergy) is well documented for CD4+ T-helper (Th) cells, although less is known about CD8+ cytotoxic T lymphocytes (CTL). One widely used method of inducing anergy of CD4+Th is presentation of antigen by ECDI (1-ethyl-3-(3-dimethylamino-propyl)carbodiimide)-fixed antigen-presenting cells (APCs). We report here that in murine mixed lymphocyte reactions (MLRs), a marked reduction in detected cytotoxicity (which is mediated predominantly by CD8+ CTL) occurs on day 7 if the bulk cultures are restimulated 2 days previously with ECDI-fixed allogeneic splenocytes. No differences were seen between untreated cultures on days 5 and 7, or on day 7 of cultures to which were added unfixed allogeneic splenocytes, fixed or unfixed syngeneic splenocytes, or 'third-party' allogeneic splenocytes, 2 days previously. The effect is not mediated directly on CD8+ cells, since MLRs depleted of CD4+ cells immediately prior to exposure to fixed allogeneic splenocytes fail to show reduced lysis. On the other hand, reduced lysis did occur if CD4+ cells, purified from the MLRs on day 4, were exposed to ECDI-fixed allogeneic splenocytes and then returned to MLRs previously depleted of CD4+ cells. Moreover the effect is overcome using exogenous interleukin-2 (IL-2). We propose that CD4+ cells, restimulated by a regimen shown previously to induce their anergy, can cause a reduction in CD(8+)-mediated cytotoxicity in MLRs.
Asunto(s)
Células Presentadoras de Antígenos/efectos de los fármacos , Linfocitos T CD4-Positivos/inmunología , Citotoxicidad Inmunológica/inmunología , Linfocitos T Citotóxicos/inmunología , Animales , Células Presentadoras de Antígenos/inmunología , Anergia Clonal , Etildimetilaminopropil Carbodiimida/farmacología , Interleucina-2/inmunología , Prueba de Cultivo Mixto de Linfocitos , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Bazo/inmunologíaRESUMEN
There is evidence to suggest that non-comedo cases of ductal carcinoma in situ (DCIS) may have a lower risk of progressing to invasive disease than comedo DCIS and may be managed with less radical treatment. Most cases of DCIS present as calcifications on the mammogram and, due to differences in the tumour architecture, comedo calcifications often have a characteristic linear or branching appearance. In this study, computer methods were developed to identify the comedo cases using the imaging features of individual calcifications and of calcification clusters. Classifier performance was measured using the area under the receiver operating characteristic (ROC) curve and was optimized by systematic testing of many different combinations of these features. On a test-set of 42 cases the computer achieved a ROC curve area of 0.91 using six combined cluster features. These results are encouraging given the observed overlap in appearance between the comedo and non-comedo cases.
Asunto(s)
Neoplasias de la Mama/diagnóstico por imagen , Calcinosis/diagnóstico por imagen , Carcinoma in Situ/diagnóstico por imagen , Carcinoma Ductal de Mama/diagnóstico por imagen , Procesamiento de Imagen Asistido por Computador/métodos , Enfermedades de la Mama/diagnóstico por imagen , Neoplasias de la Mama/clasificación , Neoplasias de la Mama/complicaciones , Calcinosis/etiología , Carcinoma in Situ/clasificación , Carcinoma in Situ/complicaciones , Carcinoma Ductal de Mama/clasificación , Carcinoma Ductal de Mama/complicaciones , Femenino , Humanos , Mamografía , Curva ROCRESUMEN
Salmon calcitonin was administered intraperitoneally (0.1, 10, 1000 ng/100 g of fish) to freshwater-adapted, immature, female brown trout, Salmo trutta, and changes in serum calcium levels were determined. The lowest dose (0.1 ng) had an effect similar to injection of saline (control), but the higher doses produced hypercalcemia. These latter effects were associated with increased serum levels of calcitonin. Maintaining immature brown trout in waters containing 20 and 50 mM calcium chloride resulted in a significant lowering of serum calcitonin with time although serum calcium levels remained stable. The extent of the decrease in serum calcitonin increased with the higher levels of environmental calcium.